PPE manufacturers urge Congress to reauthorize pandemic preparedness bill

The American Medical Manufacturers Association is calling on Congress to quickly reauthorize the Pandemic and All-Hazards Preparedness Act before the end of the 118th Congressional Session in January 2025. 

Advertisement

In a Nov. 19 news release from the agency, AMMA Executive Director Eric Axel emphasized that the reauthorization is critical for ensuring U.S. resilience in future crises including pandemics, natural disasters and other emergencies. 

AMMA highlighted the importance of maintaining robust funding for the Assistant Secretary for Preparedness and Response, which plays a key role in preparing for and responding to emergencies. The group also advocates for targeted tariffs “support domestic industries and reduce our reliance on imports,” according to the release. 

Reauthorizing PAHPA, according to AMMA, would reinforce life-saving programs, protect public health and build a stronger, more self-reliant supply chain. 

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.